RTW Biotech Opportunities (LON:RTW) Stock Jumps 0.4% – Here’s Why

RTW Biotech Opportunities (LON:RTW) shot up 0.4% during mid-day trading on Tuesday. The stock traded as high as GBX 2.36 and last traded at GBX 2.33. 742,877 shares changed hands during mid-day trading, an increase of 13% from the average daily volume of 655,721 shares. The stock had previously closed at GBX 2.32.

RTW Biotech Opportunities Price Performance

The business has a 50-day moving average price of GBX 2.44 and a 200 day moving average price of GBX 2.30. The company has a market cap of £7.23 million, a price-to-earnings ratio of 0.04 and a beta of 0.77. The company has a current ratio of 0.26, a quick ratio of 0.81 and a debt-to-equity ratio of 22.80.

RTW Biotech Opportunities Company Profile

RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.